Ion Channels in Drug Discovery—a Granular Report Addressing Pharmaceutical Companies Target Market

Prevalence of Parkinson’s disease, autoimmune dysfunction and cardiac arrhythmias has brought a paradigm shift in their treatment through ion channel modulators. The rising footprint of drug discovery has furthered the penetration of ion channels. Drug discovery, with the support of ion channel targeted mechanism of action, accounts for around 12% to 15% of the research studies. Moreover, in 2022, there were 19% of marketed drugs, further validating ion channels as the third largest group of target proteins in drug discovery. 

Ion channel-based drug development will be pronounced following the completion of human genome sequencing in April 2022. Pharmaceutical companies could unlock growth potentials with an infusion of funds into R&D activities and outsourcing. 

The final report, along with the database, will deep-dive into, including but not limited to:

• Assessment of ligand-gated ion channels and voltage-gated channels.

• Insights on preclinical development, target identification & screening, target validation & functional informatics and lead identification & candidate optimization.

• Deliberate upon potassium-, calcium- and sodium –channels. 

• Competitive landscape and inputs on the ion channel drug discovery outsourcing services

Get your copy or request for a free sample of the report “Ion Channels in Drug Discovery, 2023 Report,” compiled and published by Grand View Research.

Ion Channels in Drug Discovery Report Scope

Attribute	Details
Key Driver Analysis	Increase in research activity in ion channel-based drug discovery The outspread potential of ion channel drug discovery
Key challenges	Challenges associated with the drugs targeting ion channel Outsourcing-related quality compliance issues
Categorization of Ion Channels	Segment Analysis, by Mechanism Market revenue, by Product Mechanism Segment Analysis, by Ion Selectivity Market revenue, by Ion Selectivity Segment Analysis, by Workflow Market revenue, by Workflow
Regional Analysis	Market performance across the 5 regions

Get more insights from our in-depth market intelligence report “Drug Discovery Informatics Market Size, Share & Trends Analysis Report By Mode (In-house, Outsourced), By Workflow (Discovery, Development), By Services (Sequence Analysis Platforms, Docking), And Segment Forecasts, 2021 – 2028”

About Us

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.

Find More information @ https://www.grandviewresearch.com/info/trend-reports